Showing posts with label (methyl 1-[N6-(3-iodobenzyl)-adenin-9-yl]-b-D-ribofuronamide). Show all posts
Showing posts with label (methyl 1-[N6-(3-iodobenzyl)-adenin-9-yl]-b-D-ribofuronamide). Show all posts
Friday, March 13, 2015

Can-Fite BioPharma completes RA Phase III study of lead drug candidate CF101

›
Can-Fite BioPharma Ltd.  a biotechnology company with a pipeline of proprietary small molecule drugs that address inflammatory and...